Search
for
Sort by
Research 30 of 1000+
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- FDA Approved pediatric antihypertensive agents
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- FDA approves label addition for PDE-5 inhibitor
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Repurposing of Linagliptin Similar FDA Approved Drugs as Antidiabetic Agents
- Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical <i>in silico/in vitro</i> screening methods
- The US FDA has approved the marketing of generic finasteride 5mg tablets by Actavis.
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules
- A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test
- Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools
- A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology.
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Expert System for Hair Loss Diagnosis and Treatment
- Low level laser therapy and hair regrowth: an evidence-based review
- Nanotechnology-Based Cosmetics for Hair Care
- A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention
- Photobiomodulation devices for hair regrowth and wound healing: a therapy full of promise but a literature full of confusion
- Bidirectional Barbed Sutures for Wound Closure: Evolution and Applications
- Robotic Hair Restoration
- ANDROGENETIC ALOPECIA
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Laser Resurfacing
- Photobiomodulation therapy for androgenetic alopecia: A clinician’s guide to home-use devices cleared by the Federal Drug Administration